The Management of Bladder Cancer: Diagnosis and Treatment Recomendations

(AUA) published a report by Smith and associates on the Bladder Cancer Clinical … T1 and Tis) (AUA Guideline) produced by the AUA’s Bladder Cancer

More PDF Content

Chapter 1: The Management of Bladder Cancer: Diagnosis and Treatment, Recommendations, Introduction, Background, Epidemiology, Etiology, Molecular Mechanisms of Urothelial Carcinogenesis, Major Pathologic Subtypes, Presentation and Diagnosis, Urine-based Markers, Fluorescence Cystoscopy, Diagnostic Transurethral Reof Bladder Tumor, Tumor Characteristics, Staging, Table 1: Staging of primary tumors (T) in bladder cancer47, Grading, Table 2: 2004 World Health Organization/ International Society of Urologic Pathologists, Classification of Nonmuscle Invasive Urothelial Neoplasia59, Other Prognostic Indicators, Risk Stratification, Treatment Alternatives, Table 3. Current Treatment Alternatives, Treatment, Indication(s), Table 4. Intravesical Immunotherapy and Chemotherapy, Agent, Mechanism of Action, Transurethral Reof Bladder Tumor, Intravesical Chemotherapy and Immunotherapy, Bacillus Calmette-Guerin, Interferon, Thiotepa, Mitomycin C, Intercalating Agents (Doxorubicin, Epirubicin, and Valrubicin), Gemcitabine, Other Therapies, Photodynamic Therapy, Laser Ablation Therapy, Conservative Management, Follow-up, Methodology, Literature Search and Data Extraction, Evidence Combination

Download The Management of Bladder Cancer: Diagnosis and Treatment Recomendations pdf from, 51 pages, 155.25KB.